Lakefront Biotherapeutics
LKFT----
Lakefront Biotherapeutics (LKFT)
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The com...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Lakefront Biotherapeutics Analyst Rating
View MoreForecast & Rating
Jul 10, 2026Price forecast
$25.30-9.13%
Forecast & RatingHold
5analysts
- Strong buy0.00%
- Buy0.00%
- Hold80.00%
- Sell20.00%
- Strong sell0.00%
News
- Global Report · Jul 22 at 04:18 AM
The Island of Misfit Stocks: Cash Cows and Sleepwalkers
- Unusual Whales · Jul 13 at 03:03 PM
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
- PUBT · Jul 13 at 03:01 PM
Lakefront Biotherapeutics director Paulo Fontoura steps down after taking Sanofi R&D chief role
- Tip Ranks · Jul 7 at 03:47 PM
Lakefront Biotherapeutics Buys Back Over 104,000 Shares Under June 2026 Repurchase Program
- Unusual Whales · Jun 29 at 03:02 PM
Lakefront Receives Transparency Notification from Madison Avenue Partners
- PUBT · Jun 29 at 03:01 PM
Madison Avenue Partners discloses 5.31% stake in Lakefront Biotherapeutics
